Evidence suggests that early-life exposure to endocrine-disrupting chemicals might contribute to the development of reproductive disorders. Here, Julie Boberg and colleagues summarize the current knowledge of how environmental chemicals and pharmaceuticals potentially contribute to the development of ovarian dysgenesis syndrome.
- Hanna Katarina Lilith Johansson
- Terje Svingen
- Julie Boberg
